Danaher Corporation Intrinsic Value Calculation – DANAHER CORPORATION Reports Second Quarter FY2023 Earnings Results
August 2, 2023
🌥️Earnings Overview
The second quarter of FY2023 for DANAHER CORPORATION ($NYSE:DHR) ended on June 30 2023, with total revenue of USD 7.2 billion – down 7.6% from the same period one year prior. Net income for this quarter decreased 33.9% from the year-on-year figure, totaling USD 1.1 billion.
Market Price
Despite a slight decrease of 0.9% in its stock price from the closing price of 258.0 the day before, the company opened at $247.9 and closed at $255.7. In addition to their strong financial results, the company also announced plans to launch several new product lines in the upcoming year, which are expected to significantly contribute to their future growth. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Danaher Corporation. More…
| Total Revenues | Net Income | Net Margin |
| 30.36k | 6.3k | 21.4% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Danaher Corporation. More…
| Operations | Investing | Financing |
| 8.42k | -2.07k | -1.61k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Danaher Corporation. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 84.9k | 33.18k | 70.06 |
Key Ratios Snapshot
Some of the financial key ratios for Danaher Corporation are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 17.1% | 31.9% | 24.9% |
| FCF Margin | ROE | ROA |
| 23.7% | 9.2% | 5.6% |
Analysis – Danaher Corporation Intrinsic Value Calculation
At GoodWhale, we have conducted a deep dive into the fundamentals of DANAHER CORPORATION to provide investors with insight into the intrinsic value of the company. After rigorous analysis, our proprietary Valuation Line tool has determined that the fair value of DANAHER CORPORATION share is around $273.5. At the time of writing, DANAHER CORPORATION stock is trading at $255.7, making it a fair price that is currently undervalued by 6.5%. For investors who are looking for a good investment opportunity, DANAHER CORPORATION may be an attractive option. We recommend investors assess the company’s fundamentals to decide if it is an appropriate fit for their portfolio. More…
Peers
Danaher Corp is a large company that operates in many different industries. Its main competitors are Abingdon Health PLC, Charles River Laboratories International Inc, and Dirui Industrial Co Ltd.
– Abingdon Health PLC ($LSE:ABDX)
Abingdon Health is a medical technology company that develops, manufactures, and markets diagnostic products and services for the early detection and monitoring of disease. The company has a market capitalization of 8.22 million as of 2022 and a return on equity of -39.58%. Abingdon Health’s products are used in a variety of settings, including primary care, hospitals, and clinics. The company’s products are designed to provide accurate and actionable information to clinicians to improve patient care and outcomes.
– Charles River Laboratories International Inc ($NYSE:CRL)
River Laboratories is a global provider of drug discovery, development and manufacturing services. The company has a market cap of $10.15 billion and a return on equity of 13.86%. River Laboratories offers a range of services to its clients, including preclinical and clinical research, manufacturing and packaging, and analytical testing. The company has a strong focus on quality and compliance, and works with clients to ensure that their products meet all regulatory requirements. River Laboratories is headquartered in Wilmington, Massachusetts.
– Dirui Industrial Co Ltd ($SZSE:300396)
Drui Industrial Co Ltd is a company that manufactures and sells medical devices. The company has a market cap of 6.61B as of 2022 and a ROE of 8.7%. The company’s products include medical equipment, such as X-ray machines, ultrasound machines, and CT scanners. The company also manufactures and sells medical supplies, such as gloves, gowns, and masks.
Summary
Danaher Corporation reported their earnings results for the second quarter of FY2023, with a total revenue of USD 7.2 billion, a decrease of 7.6% year-on-year. Net income for the quarter was USD 1.1 billion, a decrease of 33.9% year-on-year. For investors, the financial performance of the company could be seen as a sign of caution as the revenue and income figures are declining. As such, investors should closely monitor Danaher Corporation’s progress to assess the effect of these changes in the upcoming quarters.
